Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Gopinathan

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|March 1, 1982
The use of lisuride, a potent dopamine and serotonin agonist, in the treatment of progressive supranuclear palsyA Neophytides, A N Lieberman, M Goldstein, et al.
Clinical Pharmacology and Therapeutics|July 1, 1982
The use of pergolide, a potent dopamine agonist, in Parkinson's diseaseA N Lieberman, M Goldstein, A Neophytides, et al.
Neurology|November 1, 1981
Lisuride combined with levodopa in advanced Parkinson diseaseA N Lieberman, M Goldstein, M Leibowitz, et al.
Journal of Dental Research|August 9, 2020
SETD1 and NF-κB Regulate Periodontal Inflammation through H3K4 TrimethylationM Francis, G Gopinathan, A Salapatas, et al.
Radiology|November 1, 1983
Acquired immunodeficiency syndrome: cerebral computed tomographic manifestationsM A Whelan, I I Kricheff, M Handler, et al.
Journal of Dental Research|August 9, 2020
Histone Methylation: Achilles Heel and Powerful Mediator of Periodontal HomeostasisM Francis, G Gopinathan, D Foyle, et al.
Neurology|October 1, 1982
Further studies with pergolide in Parkinson diseaseA N Lieberman, M Goldstein, G Gopinathan, et al.
Neurology|February 1, 1984
Long-term treatment with pergolide: decreased efficacy with timeA N Lieberman, M Goldstein, M Leibowitz, et al.
New York State Journal of Medicine|November 1, 1981
Use of lisuride in advanced Parkinson's disease. Potent dopamine and serotonin agonistA N Lieberman, M Goldstein, A Neophytides, et al.
Advances in Neurology|January 1, 1983
Comparative efficacy of pergolide and bromocriptine in patients with advanced Parkinson's diseaseA N Lieberman, A Neophytides, M Leibowitz, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Journal of Neurology, Neurosurgery, and Psychiatry|March 1, 1982
The use of lisuride, a potent dopamine and serotonin agonist, in the treatment of progressive supranuclear palsyA Neophytides, A N Lieberman, M Goldstein, et al.
Clinical Pharmacology and Therapeutics|July 1, 1982
The use of pergolide, a potent dopamine agonist, in Parkinson's diseaseA N Lieberman, M Goldstein, A Neophytides, et al.
Neurology|November 1, 1981
Lisuride combined with levodopa in advanced Parkinson diseaseA N Lieberman, M Goldstein, M Leibowitz, et al.
Journal of Dental Research|August 9, 2020
SETD1 and NF-κB Regulate Periodontal Inflammation through H3K4 TrimethylationM Francis, G Gopinathan, A Salapatas, et al.
Radiology|November 1, 1983
Acquired immunodeficiency syndrome: cerebral computed tomographic manifestationsM A Whelan, I I Kricheff, M Handler, et al.
Journal of Dental Research|August 9, 2020
Histone Methylation: Achilles Heel and Powerful Mediator of Periodontal HomeostasisM Francis, G Gopinathan, D Foyle, et al.
Neurology|October 1, 1982
Further studies with pergolide in Parkinson diseaseA N Lieberman, M Goldstein, G Gopinathan, et al.
Neurology|February 1, 1984
Long-term treatment with pergolide: decreased efficacy with timeA N Lieberman, M Goldstein, M Leibowitz, et al.
New York State Journal of Medicine|November 1, 1981
Use of lisuride in advanced Parkinson's disease. Potent dopamine and serotonin agonistA N Lieberman, M Goldstein, A Neophytides, et al.
Advances in Neurology|January 1, 1983
Comparative efficacy of pergolide and bromocriptine in patients with advanced Parkinson's diseaseA N Lieberman, A Neophytides, M Leibowitz, et al.
Pageof 5